The Design of Clinical Trials for Cell Transplantation into the Central Nervous System

被引:6
作者
Cesaro P. [1 ]
机构
[1] Department of Clinical Neurosciences, Institut National de la Santé, la Recherche Médicale U 421 Hospital Henri Mondor
来源
NeuroRX | 2004年 / 1卷 / 4期
关键词
Positron Emission Tomography Imaging; Multiple System Atrophy; Pilot Trial; Olfactory Mucosa; Pure Cell Line;
D O I
10.1602/neurorx.1.4.492
中图分类号
学科分类号
摘要
[No abstract available]
引用
收藏
页码:492 / 499
页数:7
相关论文
共 43 条
[1]  
Polgar S., Morris M., Reilly S., Bilney B., Sanberg P., Reconstructive neurosurgery for Parkinson's disease: a systematic review and preliminary meta-analysis, Brain Res Bull, 60, pp. 1-24, (2003)
[2]  
Schumacher J., Ellias S., Palmer E., Kott H., Dinsmore J., Dempsey P., Fischman A., Thomas C., Feldman R., Kassissieh S., Raineri R., Manhart C., Penney D., Fink J., Isacson O., Transplantation of embryonic porcine mesencephalic tissue in patients with PD, Neurology, 54, pp. 1042-1050, (2000)
[3]  
Bjorklund A., Lindvall O., Cell replacement therapies for central nervous system disorders, Nat Neurosci, 3, pp. 537-544, (2000)
[4]  
Dunnet S., Transplantation of embryonic dopamine neurons: what we know from rats, J Neurol, 238, pp. 65-74, (1991)
[5]  
Folkerth R., Durso R., Survival and proliferation of non-neural tissue with obstruction of cerebral ventricles in a parkinsonian patient treated with fetal allograft, Neurology, 46, pp. 1219-1224, (1996)
[6]  
Shulkin D., Kinosian B., Glick H., Sirio C., Glen-Puschett C., Daly J., Explaining cost variations in clinical trials using severity of illness measures, Clin Perform Qual Health Care, 1, pp. 134-137, (1993)
[7]  
Brooks D., Salmon E., Mathias C., Et al., The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET, Brain, 113, pp. 1539-1552, (1990)
[8]  
Remy P., Samson Y., Hantraye P., Fontaine A., Defer G., Mangin J., Et al., Neural grafting in five parkinsonian patients: correlations between PET and clinical evolution, Ann Neurol, 38, pp. 580-588, (1995)
[9]  
Wenning G., Odin P., Morrish P., Rehncrona S., Widner H., Brundin P., Rothwell J., Brown R., Gustavvii B., Hagell P., Jahanshahi M., Sawle G., Bjorklund A., Brooks D., Marsden C., Quinn N., Lindvall O., Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease, Ann Neurol, 42, pp. 95-107, (1997)
[10]  
Kordower J., Goetz C., Freeman T., Olanow C., Dopaminergic transplants in patients with Parkinson's disease: neuroanatomical correlates of clinical recovery, Exp Neurol, 144, pp. 41-46, (1997)